Thu, September 3, 2020
Wed, September 2, 2020
Tue, September 1, 2020

Andrew Baum Maintained (ABBV) at Strong Buy with Increased Target to $105 on, Sep 2nd, 2020

Andrew Baum of Citigroup, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $98 to $105 on, Sep 2nd, 2020.

Andrew has made no other calls on ABBV in the last 4 months.



There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Initiated at Hold and Held Target at $95 on, Monday, May 18th, 2020


These are the ratings of the 7 analyists that currently disagree with Andrew


  • David Risinger of "Morgan Stanley" Maintained at Buy with Increased Target to $108 on, Thursday, August 20th, 2020
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $127 on, Monday, August 3rd, 2020
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $111 on, Monday, August 3rd, 2020
  • Steve Chesney of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $115 on, Tuesday, June 23rd, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Wednesday, June 17th, 2020
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $115 on, Tuesday, June 2nd, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Monday, May 11th, 2020